Skip to main content
. 2018 Apr 17;18(7):1774–1782. doi: 10.1111/ajt.14738

Figure 3.

Figure 3

Mean estimated GFR (observed) in the subsets of patients with preexisting DSAs in (A) BENEFIT and (B) BENEFIT‐EXT. CI, confidence interval; DSA, donor‐specific antibodies; eGFR, estimated GFR; LI, less intense; MI, more intense